What Happens When You Stop Taking Jardiance?

Stopping Jardiance can quickly remove its blood sugar control effect and may raise diabetes-related risks if no replacement plan is used.

Understanding the Role of Jardiance in Diabetes Management

Jardiance, also known by its generic name empagliflozin, is a medication commonly prescribed to help manage type 2 diabetes. It belongs to a class called sodium-glucose co-transporter 2 (SGLT2) inhibitors. These drugs work by reducing how much glucose the kidneys reabsorb back into the bloodstream, causing more glucose to leave the body through urine. This unique mechanism helps lower blood sugar levels effectively, and the official Jardiance prescribing information also lists important uses for reducing cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, reducing cardiovascular death and hospitalization for heart failure in adults with heart failure, and reducing certain kidney and cardiovascular outcomes in adults with chronic kidney disease at risk of progression.

Beyond glucose control, Jardiance has shown significant cardiovascular and kidney-related benefits in the right patient groups. These benefits do not mean the medicine is risk-free or that every person gets the same result, but they explain why many patients rely on Jardiance as a key part of their treatment plan.

However, stopping Jardiance abruptly can disrupt this delicate balance. Understanding what happens when you stop taking Jardiance is crucial for anyone managing diabetes, heart failure, kidney disease, or considering changes to their medication regimen.

Immediate Effects After Stopping Jardiance

When you stop taking Jardiance, the most immediate change is in how your kidneys handle glucose. Since the medication lowers glucose reabsorption, discontinuing it allows more filtered glucose to be retained again. This can lead to an increase in blood sugar levels, especially if no other medication, diet change, or exercise plan replaces the lost effect.

Patients might notice a rise in fasting blood glucose and post-meal blood sugar within days or weeks after stopping Jardiance. The exact timing varies because it depends on baseline blood sugar control, kidney function, diet, activity level, insulin production, and other diabetes medications.

Additionally, because Jardiance causes osmotic diuresis, or increased fluid loss through urine, stopping it may reduce that diuretic effect. Some people may notice less frequent urination, small weight changes, or a different fluid balance. New swelling, shortness of breath, or rapid weight gain should be discussed with a healthcare provider, especially in people with heart failure or kidney disease.

Blood Sugar Fluctuations Explained

The kidneys filter a large amount of glucose every day, and most of it is normally reabsorbed. Jardiance blocks part of the SGLT2 pathway, lowers the renal threshold for glucose, and increases urinary glucose excretion. When you stop taking it, that glucose-losing effect falls away.

This means your body may retain more glucose instead of excreting it. Blood sugar levels can rise unless other medications, meal planning, activity, or lifestyle factors compensate for this change.

In some cases, people might experience symptoms like increased thirst, frequent urination, fatigue, headaches, or blurred vision due to elevated blood sugars after stopping Jardiance. Very high readings, vomiting, confusion, dehydration, or trouble breathing need urgent medical attention.

Long-Term Risks Associated with Stopping Jardiance

Discontinuing Jardiance without proper medical guidance may increase the risk of several problems related to uncontrolled diabetes or loss of cardiorenal protection:

Worsening Glycemic Control: Higher HbA1c and fasting glucose levels over time can increase the risk for neuropathy, retinopathy, nephropathy, and other diabetes complications.
Cardiovascular Risk Management Gaps: The heart-related benefits of Jardiance are no longer being provided once the drug is stopped. The actual risk depends on the person’s heart history, kidney function, blood pressure, cholesterol, and replacement treatment plan.
Weight Changes: Without the medication’s glucose loss through urine and mild fluid effect, some people may notice weight changes, although this is not guaranteed.
Fluid Balance Changes: Stopping can change urination and fluid balance, which matters most for patients with heart failure, chronic kidney disease, or those taking diuretics.

These risks highlight why abrupt cessation without alternative strategies or close monitoring can be unsafe. The danger is usually not “withdrawal” from Jardiance itself; it is the loss of blood sugar, heart, and kidney support that the treatment was providing.

The Importance of Medical Supervision

If you or someone you know needs to stop taking Jardiance—whether due to side effects, cost issues, surgery, illness, kidney function changes, or other reasons—it’s vital to do so under medical supervision. Healthcare providers can adjust other medications or recommend lifestyle changes that help maintain glycemic control and reduce cardiovascular risk during transition periods.

They may also monitor kidney function, blood pressure, ketone risk in certain situations, hydration status, and electrolyte balance, since empagliflozin affects renal handling of glucose and fluids.

Side Effects Leading Patients to Stop Taking Jardiance

Some patients stop taking Jardiance because they experience side effects that outweigh perceived benefits. Understanding these adverse effects clarifies why cessation sometimes occurs:

Genital Infections: Due to increased urinary glucose excretion, there is a higher risk of genital yeast infections.
Urinary Tract Infections (UTIs): UTIs can occur, and serious urinary infections have been reported, though not every patient is affected.
Dehydration and Low Blood Pressure: The diuretic effect can cause dizziness, dehydration, or low blood pressure in susceptible individuals.
Ketoacidosis Risk: Though uncommon, SGLT2 inhibitors can be linked with ketoacidosis, sometimes even when blood sugar is not extremely high. This is one reason sick-day instructions and surgical hold instructions matter.

When these side effects become severe, recurrent, or persistent, discontinuation might be necessary, but it should be planned with a clinician whenever possible.

Tackling Side Effects Before Stopping Medication

Before deciding to stop Jardiance outright due to side effects, patients should discuss mitigation strategies with their healthcare providers:

Proper hygiene practices can reduce genital infection risks for some people.
Adequate hydration helps prevent dehydration-related symptoms, but people with heart failure or kidney disease should follow individualized fluid advice.
Dose review or medication adjustment may lessen adverse effects without losing therapeutic benefit.
Temporary interruption may be needed around surgery, prolonged fasting, or acute illness, depending on medical advice.

This approach often allows continued use while minimizing discomfort, but repeated infections, dehydration, ketoacidosis symptoms, or serious kidney concerns should never be ignored.

The Impact on Cardiovascular Health After Stopping Jardiance

Jardiance’s cardiovascular benefits are well documented in specific patient groups, especially heart failure patients and adults with type 2 diabetes who also have established cardiovascular disease. These benefits stem partly from glucose control, but also from effects on fluid balance, blood pressure, heart failure outcomes, and kidney protection.

Stopping the drug means these protective mechanisms are no longer being actively provided. This does not mean a heart attack, stroke, or heart failure flare will happen immediately after the last dose, but patients with existing heart disease or heart failure may become more vulnerable if no replacement strategy is used:

The risk of heart failure worsening may rise over time if fluid balance, blood pressure, and other heart failure treatments are not optimized.
Systolic blood pressure may return toward baseline after previously being modestly lowered by the medication.
Overall cardiovascular risk needs to be managed through the full treatment plan, including blood pressure control, cholesterol management, diabetes control, kidney protection, smoking cessation if relevant, and other prescribed therapies.

Therefore, stopping Jardiance should involve a clear plan addressing cardiovascular risk management through other means if needed.

A Closer Look at Cardiovascular Markers Post-Cessation

Marker	Status While on Jardiance	Status After Stopping Jardiance
Systolic Blood Pressure (mmHg)	May be modestly lower in some patients	May return toward baseline, depending on other medicines and health status
B-type Natriuretic Peptide (BNP)	May improve in some heart failure patients as congestion improves	Not predictable; may worsen if heart failure or fluid overload worsens
Kidney Function (eGFR)	An early small eGFR dip can occur, followed by longer-term kidney protection in eligible patients	The early hemodynamic dip may reverse, but long-term protective benefit is no longer being provided
CVD Event Risk	Reduced cardiovascular death risk in adults with type 2 diabetes and established cardiovascular disease	Risk depends on the replacement plan and the patient’s baseline cardiovascular disease
Hospitalization for Heart Failure (HHF)	Reduced in heart failure trials	Risk may rise over time if heart failure is not otherwise well controlled

This table gives a practical overview, not a precise prediction for every patient. Individual risk can vary widely based on age, kidney function, heart failure status, diabetes control, and the rest of the treatment plan.

The Effect on Kidney Function When Discontinuing Jardiance

Jardiance also plays a role in protecting kidney function by affecting sodium-glucose transport in the proximal tubules and reducing pressure stress inside the kidney’s filtering system. This can help slow progression of diabetic kidney disease or chronic kidney disease in eligible patients. The ADA Standards of Care for chronic kidney disease and risk management recommend SGLT2 inhibitors for many people with type 2 diabetes and chronic kidney disease who meet kidney-function criteria, because they reduce CKD progression and cardiovascular events.

Stopping empagliflozin ends the ongoing kidney-protective effect. Over time:

The long-term slowing of kidney disease progression may be lost unless another effective strategy is used.
The risk of albuminuria or worsening kidney markers may increase if blood sugar, blood pressure, and kidney disease are not managed well.
The likelihood of serious kidney outcomes may be higher in high-risk patients if glycemic control, blood pressure control, and kidney-protective therapy worsen together.

For those with pre-existing chronic kidney disease (CKD), stopping could mean less protection unless alternative treatments are implemented promptly. This is especially important for people who already have reduced eGFR, albumin in the urine, heart failure, or multiple diabetes complications.

Kidney Function Changes: A Timeline Post-Jardiance Withdrawal

The initial weeks after stopping may show minimal changes or even a small reversal of the early eGFR dip that can occur when starting the medicine. However, over months, patients may lose the longer-term kidney-protective benefit if blood sugars, blood pressure, and albuminuria are not controlled. Careful monitoring every 3-6 months is often advisable during this period, though the exact schedule should come from a healthcare provider.

Dietary and Lifestyle Adjustments After Stopping Jardiance

If you must stop taking Jardiance—either temporarily or permanently—proactive steps become essential to maintain metabolic health:

Dietary Focus: Prioritize high-fiber, lower-glycemic foods such as vegetables, legumes, whole grains, nuts, seeds, and lean proteins, while limiting sugary drinks and refined carbohydrates that can spike blood sugar quickly.
Regular Physical Activity: Exercise improves insulin sensitivity and aids weight management, which becomes even more important when medication support changes.
Adequate Hydration: Maintaining fluid balance supports kidney health, but patients with heart failure or kidney disease should follow their clinician’s fluid and sodium guidance.
Mental Health Support: Managing stress may help reduce cortisol-related blood sugar spikes and make medication and lifestyle plans easier to follow.
Cautious Monitoring: More frequent blood glucose testing can identify early signs of worsening control so treatment adjustments can be made quickly.

Taking charge through lifestyle modifications can support recovery and stability, but lifestyle changes should complement—not replace—medical advice when stopping drugs like Jardiance.

Tapering Off Versus Abrupt Discontinuation: What’s Safer?

Abruptly stopping any long-term medication can create problems if the condition being treated is still active. With Jardiance, tapering is not usually required to prevent a classic withdrawal syndrome, because it does not work like a sedative, steroid, or opioid. However, stopping suddenly without a replacement plan can still cause blood sugar to rise or leave heart and kidney risks less protected.

That said:

A planned step-down or stop date combined with increased monitoring offers safety nets against sudden metabolic changes.
Your doctor might adjust other antidiabetic agents such as metformin, insulin, GLP-1 receptor agonists, DPP-4 inhibitors, or other medicines depending on your profile.
This strategy can reduce sharp rebounds in blood sugar while maintaining overall stability during transition periods.

Abrupt discontinuation without follow-up care raises chances for uncontrolled hyperglycemia and its consequences. The safest path is not always “taper slowly”; it is “stop only with a clear plan.”

The Financial Aspect: Can Cost Influence Discontinuation?

The expense associated with newer diabetes medications such as Jardiance sometimes leads people to stop treatment prematurely. Insurance coverage varies widely; out-of-pocket costs can be high depending on location and plan specifics.

Stopping due to cost pressures often results in poorer health outcomes because alternatives may not offer equivalent glucose, heart, or kidney benefits immediately. Still, there may be safer options than stopping without telling anyone.

Patients facing financial barriers should ask their healthcare provider, pharmacist, insurer, clinic, or social worker about lower-cost alternatives, formulary exceptions, coupons, manufacturer support, or patient assistance programs before halting medication independently.

Key Takeaways: What Happens When You Stop Taking Jardiance?

➤ Blood sugar levels may rise after stopping the medication.

➤ Heart protection may no longer be active without Jardiance or another plan.

➤ Weight and fluid balance may change after the medicine is stopped.

➤ Kidney protection effects may lessen over time.

➤ Consult your doctor before making any medication changes.

Frequently Asked Questions

What Happens When You Stop Taking Jardiance Suddenly?

Stopping Jardiance suddenly can cause your kidneys to retain more glucose again, which may raise blood sugar levels. This can increase the risk of diabetes complications over time if blood sugar is not managed with another treatment plan.

How Does Stopping Jardiance Affect Blood Sugar Control?

When you stop Jardiance, the medication’s glucose-lowering effect ends quickly. Your kidneys stop losing as much glucose through urine, so fasting and post-meal blood sugar may rise unless diet, activity, or other medications compensate.

Can Stopping Jardiance Cause Fluid Retention or Weight Gain?

It can change fluid balance because Jardiance promotes mild fluid loss through urine. Some people may notice small weight or urination changes after stopping. Sudden swelling, shortness of breath, or rapid weight gain should be checked promptly, especially in heart failure patients.

Are There Increased Risks of Diabetes Complications After Stopping Jardiance?

Discontinuing Jardiance can remove its blood sugar, heart, and kidney support. The level of risk depends on your health conditions and whether an alternative treatment plan is started. Stopping without medical guidance is the part that creates the biggest concern.

What Should I Do If I Need to Stop Taking Jardiance?

If you plan to stop Jardiance, consult your healthcare provider first. They can guide you on safely managing blood sugar levels, watching kidney function, adjusting other medications, and reducing heart-related risk during the transition.

The Bottom Line – What Happens When You Stop Taking Jardiance?

Discontinuing Jardiance can reverse its beneficial effects quickly—blood sugar may rise within days or weeks; heart failure and cardiovascular risk support is no longer being provided; kidney protection may lessen over time; and side effects linked directly to the drug may improve. At the same time, new symptoms related to high blood sugar or fluid changes may emerge instead.

Stopping without medical guidance increases risks for serious complications including uncontrolled hyperglycemia, dehydration from high blood sugar, worsening heart failure symptoms in vulnerable patients, worsening nephropathy over time, and overall loss of metabolic control. Ketoacidosis is more directly a known risk while taking SGLT2 inhibitors or during insulin-deficient states, but anyone with vomiting, abdominal pain, confusion, severe weakness, or breathing trouble should seek urgent care.

If cessation becomes necessary due to side effects, cost, surgery, illness, kidney function concerns, or other factors:

Talk openly with your healthcare provider about safe transition plans;
Pursue lifestyle strategies rigorously;
Aim for regular blood sugar and kidney monitoring;
Avoid unplanned abrupt stops where possible;
Seek financial assistance programs or lower-cost alternatives if cost is a barrier;
Ask for clear sick-day and surgery instructions if temporary interruption is needed.

This comprehensive approach ensures safer outcomes even when leaving behind a powerful medication like Jardiance.

In essence: You don’t just stop taking Jardiance—you need a clear plan afterward because your body can feel the difference quickly.

References & Sources

DailyMed. “JARDIANCE® (empagliflozin tablets), Full Prescribing Information.” Supports Jardiance’s mechanism of action, approved indications, dosing information, warnings, and major adverse effects including ketoacidosis, volume depletion, urinary infections, and genital mycotic infections.
American Diabetes Association. “11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026.” Supports the role of SGLT2 inhibitors in reducing chronic kidney disease progression and cardiovascular events in eligible people with type 2 diabetes and chronic kidney disease.